cystic fibrosis

Wall Street IPO initial public offering markets shares stock
Biotech

Arcturus' stock halves on cystic fibrosis readout

The findings have sent the biopharma’s stock crashing, falling 55% from $23.16 per share to $10.44 per share.
Gabrielle Masson Oct 22, 2025 1:01pm
Messenger RNA

Arcturus doubles down on mRNA, axes several early-stage assets

May 13, 2025 1:32pm
pause button on blue background

Vertex takes $379M hit tied to cancelled islet cell program

May 6, 2025 12:50pm
Photo of Wall Street street sign with american flags in the background

Sionna goes public in $135M IPO, Aardvark plots $103M listing

Feb 7, 2025 4:40am
IPO initial public offering

Sionna eyes up $156M IPO to fund cystic fibrosis trials

Feb 3, 2025 9:59am
IPO initial public offering Wall Street

Odyssey, Sionna join band of biotechs braving the IPO waters

Jan 21, 2025 5:27am